Related references
Note: Only part of the references are listed.Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
Andrea Cipriani et al.
LANCET (2009)
Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents
Graham J. Emslie et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: A meta-analysis of placebo-controlled randomized trials
Nil Kaymaz et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
I. M. Anderson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
The prevention of recurrent episodes of depression with venlafaxine for two years (PREVENT) study: Outcomes from the 2-year and combined maintenance phases
Martin B. Keller et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Escitalopram prevents relapse in older patients with major depressive disorder
Philip Gorwood et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2007)
Metareview on short-term effectiveness and safety of antidepressants for depression: An evidence-based approach to inform clinical practice
Andrea Cipriani et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2007)
Escitalopram maintenance treatment for prevention of recurrent depression: A randomized, placebo-controlled trial
Susan G. Kornstein et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Sertraline for prevention of depression recurrence in diabetes mellitus - A randomized, double-blind, placebo-controlled trial
PJ Lustman et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Duloxetine in the prevention of relapse of major depressive disorder - Double-blind placebo-controlled study
DG Perahia et al.
BRITISH JOURNAL OF PSYCHIATRY (2006)
A placebo-controlled, randomized withdrawal study of sertraline for major depressive disorder in Japan
K Kamijima et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2006)
Relapse prevention with gepirone ER in outpatients with major depression
MB Keller et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
Sustained efficacy of gepirone-IR in major depressive disorder: a double-blind placebo substitution trial
JD Amsterdam et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2004)
Global burden of depressive disorders in the year 2000
TB Üstün et al.
BRITISH JOURNAL OF PSYCHIATRY (2004)
Extended-release venlafaxine in relapse prevention for patients with major depressive disorder
JS Simon et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2004)
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression
AJ Gelenberg et al.
BIOLOGICAL PSYCHIATRY (2003)
Depression and bipolar support alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life
DS Charney et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Older community residents with depression: long-term treatment with sertraline - Randomised, double-blind, placebo-controlled study
KCM Wilson et al.
BRITISH JOURNAL OF PSYCHIATRY (2003)
Frequency of positive studies among fixed and flexible dose antidepressant clinical trials: An analysis of the food and drug administraton summary basis of approval reports
A Khan et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
JR Geddes et al.
LANCET (2003)
Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo
JH Kocsis et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy
R Klysner et al.
BRITISH JOURNAL OF PSYCHIATRY (2002)
Continuation phase treatment with bupropion SR effectively decreases the risk for relapse of depression
KL Weihs et al.
BIOLOGICAL PSYCHIATRY (2002)
Placebo response in studies of major depression - Variable, substantial, and growing
BT Walsh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Efficacy of mirtazapine for prevention of depressive relapse: A placebo-controlled double-blind trial of recently remitted high-risk patients
ME Thase et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
Fluoxetine in the prevention of depressive recurrences: A double-blind study
I Gilaberte et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Prophylactic effect of citalopram in unipolar, recurrent depression - Placebo-controlled study of maintenance therapy
B Hochstrasser et al.
BRITISH JOURNAL OF PSYCHIATRY (2001)
The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder
ME Schmidt et al.
JOURNAL OF CLINICAL PSYCHIATRY (2000)
Weekly dosing of fluoxetine for the continuation phase of treatment of major depression: Results of a placebo-controlled, randomized clinical trial
WJ Burke et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2000)
Prevention of recurrent depressive episodes with milnacipran: consequences on quality of life
F Rouillon et al.
JOURNAL OF AFFECTIVE DISORDERS (2000)
Executive dysfunction and long-term outcomes of geriatric depression
GS Alexopoulos et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Share Paper
